Literature DB >> 8584617

The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. I: Antagonist correlation analysis.

D Fiorella1, R A Rabin, J C Winter.   

Abstract

Investigations conducted over the past 3 decades have demonstrated that serotonergic receptors, specifically the 5-HT2A and 5-HT2C subtypes, play an important role in the behavioral effects of hallucinogenic compounds. The present study was designed to determine the respective significance of these two receptors in the stimulus effects of LSD and (-)DOM in the rat. Specifically, the interactions of a series of serotonergic antagonists (risperidone, pirenpirone, metergoline, ketanserin, loxapine, LY53857, pizotyline, spiperone, cyprohepatadine, mesulergine, promethazine, and thioridazine) with the LSD stimulus and the (-)DOM stimulus in LSD-trained subjects was defined. From these data, IC50 values were determined for the inhibition of the LSD-appropriate responding elicited by either 0.1 mg/kg LSD (15-min pretreatment time) or 0.4 mg/kg (-)DOM (75-min pretreatment). In addition, the affinities of these antagonists for 5-HT2A and 5-HT2C receptors were determined in radioligand competition studies, 5-HT2A affinity correlated significantly with IC50 values for the blockade of the LSD (r = +0.75, P < 0.05) and (-)DOM (r = +0.95, P < 0.001) stimuli in the LSD trained subjects. 5-HT2C affinity did not correlate significantly with either series of IC50 values. These data indicate that (1) the stimulus effects of LSD, and (2) the substitution of (-)DOM for the LSD stimulus are mediated by agonist activity at 5-HT2A receptors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8584617     DOI: 10.1007/bf02246074

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  47 in total

1.  The dopamine receptor: differential binding of d-LSD and related agents to agonist and antagonist states.

Authors:  I Creese; D R Burt; S H Synder
Journal:  Life Sci       Date:  1975-12-01       Impact factor: 5.037

2.  Statistical analysis of radioligand assay data.

Authors:  D Rodbard; G R Frazier
Journal:  Methods Enzymol       Date:  1975       Impact factor: 1.600

Review 3.  Gaps and peculiarities in 5-HT2 receptor studies.

Authors:  J E Leysen
Journal:  Neuropsychopharmacology       Date:  1990 Oct-Dec       Impact factor: 7.853

4.  Binding interactions of lysergic acid diethylamide and related agents with dopamine receptors in the brain.

Authors:  D R Burt; I Creese; S H Snyder
Journal:  Mol Pharmacol       Date:  1976-07       Impact factor: 4.436

5.  Rapid desensitization and down-regulation of 5-HT2 receptors by DOM treatment.

Authors:  J E Leysen; P F Janssen; C J Niemegeers
Journal:  Eur J Pharmacol       Date:  1989-04-12       Impact factor: 4.432

6.  Blockade of the stimulus properties of mescaline by a serotonin antagonist.

Authors:  J C Winter
Journal:  Arch Int Pharmacodyn Ther       Date:  1975-04

7.  Characterization and radioautography of [3H]LSD binding by rat brain slices in vitro: the effect of 5-hydroxytryptamine.

Authors:  R C Meibach; S Maayani; J P Green
Journal:  Eur J Pharmacol       Date:  1980-10-31       Impact factor: 4.432

8.  Dopaminergic and serotonergic mediation of the discriminable effects of ergot alkaloids.

Authors:  A M Holohean; F J White; J B Appel
Journal:  Eur J Pharmacol       Date:  1982-07-30       Impact factor: 4.432

9.  Antagonism of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane stimulus with a newly identified 5-HT2- versus 5-HT1C-selective antagonist.

Authors:  A M Ismaiel; J De Los Angeles; M Teitler; S Ingher; R A Glennon
Journal:  J Med Chem       Date:  1993-08-20       Impact factor: 7.446

10.  Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents.

Authors:  R A Glennon; M Titeler; J D McKenney
Journal:  Life Sci       Date:  1984-12-17       Impact factor: 5.037

View more
  44 in total

1.  DOI-Induced activation of the cortex: dependence on 5-HT2A heteroceptors on thalamocortical glutamatergic neurons.

Authors:  J L Scruggs; S Patel; M Bubser; A Y Deutch
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

2.  Discriminative stimulus effects of serotonin agonists, neutral antagonists, and inverse agonists in pigeons: perspectives on intrinsic efficacy measurements in vivo.

Authors:  Martilias Farrell; Sharon Rosenzweig-Lipson; Ellen Walker
Journal:  Psychopharmacology (Berl)       Date:  2010-06-05       Impact factor: 4.530

Review 3.  The behavioral pharmacology of hallucinogens.

Authors:  William E Fantegrossi; Kevin S Murnane; Chad J Reissig
Journal:  Biochem Pharmacol       Date:  2007-07-20       Impact factor: 5.858

4.  Neurochemical pharmacology of psychoactive substituted N-benzylphenethylamines: High potency agonists at 5-HT2A receptors.

Authors:  Amy J Eshleman; Katherine M Wolfrum; John F Reed; Sunyoung O Kim; Robert A Johnson; Aaron Janowsky
Journal:  Biochem Pharmacol       Date:  2018-09-25       Impact factor: 5.858

5.  Serotonergic/glutamatergic interactions: the effects of mGlu2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli.

Authors:  J C Winter; J R Eckler; R A Rabin
Journal:  Psychopharmacology (Berl)       Date:  2003-11-04       Impact factor: 4.530

6.  Regioselective alkylation of 1,3,4,5-tetrahydrobenzo[d]azepin-2-one and biological evaluation of the resulting alkylated products as potentially selective 5-HT₂c agonists.

Authors:  Navnit Prajapati; Rajani Giridhar; Anshuman Sinha; Ashish M Kanhed; Mange Ram Yadav
Journal:  Mol Divers       Date:  2015-04-28       Impact factor: 2.943

7.  Differential effects of serotonin 5-HT1A receptor agonists on the discriminative stimulus effects of the 5-HT2A receptor agonist 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rats and rhesus monkeys.

Authors:  Jun-Xu Li; Wouter Koek; Kenner C Rice; Charles P France
Journal:  J Pharmacol Exp Ther       Date:  2010-01-06       Impact factor: 4.030

8.  4-Bromo-2,5-dimethoxyphenethylamine (2C-B) and structurally related phenylethylamines are potent 5-HT2A receptor antagonists in Xenopus laevis oocytes.

Authors:  Claudio A Villalobos; Paulina Bull; Patricio Sáez; Bruce K Cassels; J Pablo Huidobro-Toro
Journal:  Br J Pharmacol       Date:  2004-03-08       Impact factor: 8.739

9.  5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice.

Authors:  Adam L Halberstadt; Iris van der Heijden; Michael A Ruderman; Victoria B Risbrough; Jay A Gingrich; Mark A Geyer; Susan B Powell
Journal:  Neuropsychopharmacology       Date:  2009-03-25       Impact factor: 7.853

10.  LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor.

Authors:  Adam L Halberstadt; Mark A Geyer
Journal:  Psychopharmacology (Berl)       Date:  2009-11-25       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.